Science
-
People with Long COVID demand pause of McMaster University clinical trial
The trial, run by researchers at McMaster University in Canada, is testing the Lightning Process, a pseudoscientific mind-body program that outside experts have heavily criticized.
-
Research updates, September 22
A small study in NeuroImage: Reports has found more evidence of reduced blood flow to the brain of people with Long COVID. The authors concluded that this abnormality was linked with fatigue, after they assessed brain imaging results of 22 people with Long COVID and compared them with 19 controls.
-
Bezisterim may help with some Long COVID symptoms, drug’s developer reports in early trial results
While the phase 2 clinical trial results, shared by BioVie in a webinar on Tuesday, have yet to be peer-reviewed, investigators say they can inform a confirmatory phase 3 trial.
-
Research updates, September 15
Repeat SARS-C0V-2 infections were linked to a higher odds of new health conditions, according to a new study in the Canada Communicable Disease Report.
-
Department of Defense funds $8 million grant for Long COVID trials
A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (DOD) grant.
-
Research updates, September 1
People with Long COVID are at a higher risk for cardiovascular, renal, and pulmonary (CRP) outcomes, according to a large observational study published in Journal of the American Heart Association. The study was a retrospective study and assessed more than 2.6 million people who developed COVID-19, comparing about 158,000 people who had been diagnosed with…
-
Research updates, August 25
Another observational study found more evidence of endothelial dysfunction in Long COVID. German researchers evaluated the eyes of 102 people with Long COVID, comparing them to 102 people “recovered” from COVID-19, as well as controls.
-
Research updates, August 18
Researchers found immune abnormalities in the intestines of people with Long COVID, according to a new preprint. The small study compared colon tissue samples and blood of 44 people with Long COVID to 13 controls who “recovered” from COVID-19, using several different analysis methods.
-
VIPER aims to fast track Long COVID biomarkers. Here’s how it works.
Led by researchers at UCSF, the research program plans to validate promising candidates for noninvasive tests that can be used to advance clinical trials.
-
Research updates, August 11
COVID-19 can reactivate dormant viruses in the body, confirms new research in Nature.
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance